Category Archives: university industry collaboration

Plot twists in Soderbergh’s new movie Side Effects strain belief

Share I went to see Steven Soderbergh’s new film, Side Effects, with anticipation and dread. The movie, after all, carries the same name as my 2008 book, Side Effects and from what I could tell of the trailers, its plot … Continue reading

Posted in antidepressants, drug marketing, FDA, pharmaceutical industry, prescription drug abuse, university industry collaboration | Tagged , , , , , , , , | 2 Comments

Calls for action against authors of controversial Paxil study are getting louder

Share In the wake of GlaxoSmithKline’s record-breaking $3 billion settlement with the U.S. Department of Justice, a number of psychiatrists and researchers have redoubled their efforts to get Paxil study 329 retracted. As mentioned here and in other news accounts, the … Continue reading

Posted in antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration | Tagged , , , , , , , | 2 Comments

Why academic researchers involved in fraudulent Paxil study escape scrutiny

Share The Chronicle of Higher Education this week ponders why various universities have taken no action against the academic researchers who co-authored the notorious Paxil study that formed the crux of GlaxoSmithKline’s recent $3 billion settlement with the Department of … Continue reading

Posted in antidepressants, clinical trials, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration | Tagged , , , , , | 3 Comments

Enforcing anti-kickback laws: a powerful deterrent against ghost-writing in medicine

Share The Obama administration recently made it clear that it will require drug companies to disclose the payments they make to doctors for research, consulting, speaking, travel and entertainment under the new health care law — see the New York … Continue reading

Posted in antidepressants, conflicts of interest, continuing medical education, drug marketing, ghostwriting, pharmaceutical industry, university industry collaboration | Tagged , , , , , | Leave a comment

New drug industry partnership with hospitals could jeopardize patient care

Share We’ve all signed those vague privacy statements when visiting our local hospital for medical care. But how many of us have actually read the fine print and understand that the most sensitive details of our medical lives may be … Continue reading

Posted in biotech industry, clinical trials, conflicts of interest, patient care, pharmaceutical industry, Uncategorized, university industry collaboration | Tagged , , , , , , , | 1 Comment

Taxpayers lose out in Supreme Court ruling on who owns federally funded research

Share The current issue of the New England Journal of Medicine contains a thoughtful essay about who owns federally funded research: the universities who receive the funding or the private companies who contract with academic researchers to develop a specific … Continue reading

Posted in health care costs, university industry collaboration | Tagged , , , , , | 1 Comment

French lawmakers may mandate conflict of interest disclosures

Share At a time when our own government has stepped back from requiring true transparency about conflicts of interest in medicine, French lawmakers seem to be heading in a much bolder direction. According to Nature Medicine, the French national assembly … Continue reading

Posted in conflicts of interest, FDA, health insurers, National Institutes of Health, university industry collaboration | 1 Comment

New NIH rules about conflicts of interest are a swiss cheese of loopholes

Share The newly announced rules on financial conflicts of interest among federally funded researchers are certainly an improvement on the existing regulations issued by the National Institutes of Health in 1995 (which were never enforced anyway). But as ethicists and … Continue reading

Posted in conflicts of interest, National Institutes of Health, university industry collaboration | Tagged , , , , | 2 Comments

What’s behind the growing rate of scientific retractions?

Share The retraction of studies in medical and scientific journals has surged in the last decade, according to separate analyses done by the Wall Street Journal and Retraction Watch. In its page-one article today, the Journal noted that while just … Continue reading

Posted in drug marketing, ghostwriting, medical devices, scientific journal retractions, university industry collaboration | 2 Comments

With Big Pharma on campus, who is looking after the public interest?

Share Medicare and social services for vulnerable Americans are not the only programs on the chopping block with Washington’s deal to raise the debt ceiling and cut trillions of dollars in government spending. Looming ahead may be deep cuts in … Continue reading

Posted in antipsychotic drugs, conflicts of interest, health care costs, university industry collaboration | Leave a comment